Labmetrics

PAMA cuts are currently scheduled to resume January 31, 2026—but if history is any guide, another delay remains possible.   Congress has intervened six consecutive times to postpone PAMA reimbursement cuts since 2020. The bipartisan RESULTS Act , introduced in September 2025, would freeze Clinical Laboratory Fee Schedule rates at current 2025 levels and cancel pending cuts through 2028. Industry advocacy through the "Stop Lab Cuts" campaign continues to push for passage.   However, planning...

Your 2026 laboratory budget is approved. The capital projects are funded. The service expansions are green-lit.   Now comes the hard part: making it happen.   Strategic plans only deliver value when they move into execution. Yet many laboratories struggle to translate approved initiatives into operational results—not because the strategy was flawed, but because execution lacks structure, accountability, and consistent oversight.   Where Execution Breaks Down 📋 Undefined accountability –...

OIG enforcement is intensifying, and laboratories remain a primary focus.   False Claims Act settlements and judgments exceeded $6.8 billion in fiscal year 2025 —a record year. Laboratory-specific enforcement continues at a steady pace, with recent settlements involving kickback schemes, medically unnecessary testing, and improper referral arrangements resulting in multi-million dollar penalties and program exclusions.   For publicly traded laboratory companies, the compliance landscape is...